Breakthrough Therapy Designation: FDA Fast-Tracks AbbVie’s Temab-A in Two Cancers
The FDA gave AbbVie's experimental drug Temab-A two breakthrough therapy designations in colorectal and lung cancer. It speeds development, but it is not an approval.
AbbVie
Local weather
Finding your area…National Weather Service
Trending
- Tesla Powershare Home Backup Arrives for Model 3 and Model Y
- Texas Senate Race Poll Shows Talarico Edging Paxton, Abbott Under Pressure
- Breakthrough Therapy Designation: FDA Fast-Tracks AbbVie’s Temab-A in Two Cancers
- Texas Stock Exchange Lands Its First Big Bank: Texas Capital Moves Its Listing Home
- SEC Football Legends 2026: Mark Richt Gets Georgia’s Nod